孙 鹏,权继传,关 旭.环氧合酶-2与结直肠癌的关系及以其为靶点的治疗进展[J].肿瘤学杂志,2019,25(12):1031-1036.
环氧合酶-2与结直肠癌的关系及以其为靶点的治疗进展
Research Progress on Cyclooxygenase-2 in Colorectal Cancer and Its Application as a Therapeutic Target
投稿时间:2018-12-26  
DOI:10.11735/j.issn.1671-170X.2019.12.B002
中文关键词:  环氧合酶-2  结直肠肿瘤  增殖  血管生成  耐药
英文关键词:cyclooxygenase-2(COX-2)  colorectal cancer  proliferation  angiogenesis  drug resistance
基金项目:国家重点研发计划“精准医学研究”项目(2016YFC0905300);哈尔滨医科大学研究生创新科研项目(YJSCX2017-63HYD)
作者单位
孙 鹏 哈尔滨医科大学附属第二医院 
权继传 中国医学科学院肿瘤医院 
关 旭 中国医学科学院肿瘤医院 
摘要点击次数: 1637
全文下载次数: 355
中文摘要:
      摘 要:自20世纪70年代流行病学调查显示非甾体抗炎类药物可以降低结直肠癌患病率和死亡率,随后研究发现环氧合酶-2(COX-2)是其作用靶点,COX-2受到抑制从而影响了结直肠癌的发生和发展,但机制一直不明确。随着研究不断深入,COX-2促结直肠癌增殖、抑制凋亡作用、促血管生成作用逐渐被报道。全文结合最新研究结果对COX-2与结直肠癌发生发展的关系以及相关治疗的进展做一综述,从而更好的理解COX-2在结直肠癌中的作用,并探讨以COX-2作为结直肠癌治疗靶标的可能。
英文摘要:
      Abstract:Since 1970s,the epidemiological studies have demonstrated that non-steroidal anti-inflammatory drugs can reduce the incidence and mortality of colorectal cancer. Further studies confirmed that cyclooxygenase 2(COX-2) was the target of drug action,the inhibition of COX-2 would affect the occurrence and development of colorectal cancer,but the mechanism is still unclear. It has been reported that COX-2 promotes proliferation and inhibits apoptosis of colorectal cancer cells and enhances angiogenesis in cancer tissue. This article reviews the latest progress on the relationship between COX-2 and the development of colorectal cancer and the potential application of COX-2 as a therapeutic target for colorectal cancer.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器